Reply to "CDR2 and CDR2L Yo Antigens in Paraneoplastic Cerebellar Degeneration"

Ann Neurol. 2020 Aug;88(2):429. doi: 10.1002/ana.25794. Epub 2020 Jun 12.

Authors

Torbjørn Kråkenes¹, Ida Herdlevaer^{1

2}, Margrethe Raspotnig¹, Mette Haugen², Manja Schubert², Christian Vedeler^{1

2

3}

Affiliations

¹ Department of Clinical Medicine, University of Bergen, Bergen, Norway.
² Department of Neurology, Haukeland University Hospital, Bergen, Norway.
³ Departments of Neurology and Clinical Medicine, Neuro-SysMed-Center of Excellence for Experimental Therapy in Neurology, Bergen, Norway.

PMID: 32445220
DOI: 10.1002/ana.25794

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Humans
Paraneoplastic Cerebellar Degeneration*